Schonfeld Strategic Advisors LLC Outset Medical, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$1.94 - $4.61 $29,876 - $70,994
15,400 New
15,400 $59,000
Q2 2022

Aug 15, 2022
BUY
$13.46 - $48.16 $106,199 - $379,982
7,890 Added 161.02%
12,790 $189,000
Q1 2022

May 16, 2022
SELL
$34.22 - $47.24 $290,870 - $401,540
-8,500 Reduced 63.43%
4,900 $223,000
Q4 2021

Feb 14, 2022
BUY
$43.29 - $58.77 $369,350 - $501,425
8,532 Added 175.27%
13,400 $617,000
Q2 2021

Aug 16, 2021
SELL
$41.49 - $59.92 $436,972 - $631,077
-10,532 Reduced 68.39%
4,868 $243,000
Q1 2021

May 17, 2021
BUY
$46.94 - $58.66 $722,876 - $903,364
15,400 New
15,400 $838,000

Others Institutions Holding OM

# of Institutions
91
Shares Held
19.9M
Call Options Held
66.8K
Put Options Held
60.3K
View Full List

About Outset Medical, Inc.

OM Quotes by TradingView
  • Ticker OM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 48,007,300
  • Market Cap $54.2M
  • Description
  • Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...
More about OM
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email